Neomed Management
Overview
NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million.
Investment Focus
- Innovative solutions in healthcare and life sciences
- Strong growth potential
- Experienced management teams
- Scalable business models
- Clear regulatory pathways
Portfolio Companies
Reach Neomed Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Neomed Management
What sectors does Neomed Management invest in?
Neomed Management invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Oslo, Norway. Neomed Management is listed as a vc in the ConnectSafely investor database.
What stage does Neomed Management invest at?
Neomed Management backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1M - 50M.
Which regions does Neomed Management invest in?
Neomed Management invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Neomed Management invested in?
Neomed Management's portfolio includes Sequana Medical NV, Biocryst Pharmaceuticals, Aptinyx Inc, Aptose Biosciences and Aptose Biosciences Inc.
Last updated · Source: ConnectSafely investor database
